株譜

AI 銘柄分析 · 10年

Diploma PLC

DPLM · GBP · 分析基準日 2026-11-06

Diploma:部品流通と買収投資の10年評価

10年期待年率4.40%
資本コスト9.20%
直近終値69.90 GBP2026-11-06

AIによるシナリオ分析です。基準日以降の出来事、株価や為替の変化は個別に確認が必要です。各数値は元の分析の単位と前提に従います。

分析の要約

既存事業の成長と買収投資、従業員信託を5ケースで評価。基準日の信託保有株数と財務は代理値で、配当・買収・成長は予測です。

要約の補足

overview_jp

Controlsは航空・防衛・データセンター等で高い収益性。Sealsは産業設備/建機サイクル、Life Sciencesは診断機器・消耗品。好調な調整後利益をIFRS親会社利益と混同せず、買収無形資産償却と株式報酬を残す。

market_exposure

米国・英国・欧州・豪州等。為替換算、通商政策、半導体/データセンター設備投資、航空・防衛投資に敏感。

cutoff_data_warning

FY26 full-year results, including 2026-09-30 balance sheet, have not yet been disclosed as of Nov 6. Estimated bridge is scenario input, not a reported fact.

price_warning

dated 6 Nov close 6990 GBp cross checked by independent secondary quote vendors, official LSE date-stamped OHLC row not successfully retrieved.

growth_and_val_warning

高い調整後利益率は買収償却・価格負担を反映しない。終価は前方NI+非現金SBCと必要再投資・旧株主持分・希薄化から構成。

investment_style

valuation and capital preservation research; not trading advice

結論の補足

risk_assessed

産業用品の買収による高品質複利成長だが株価の成長期待は大きい

expected_prob_weighted_dated_xirr
0.04399385033
central_cost_of_equity
0.092
expected_PV_per_starting_share_gbp
45.836858
reference_price_gbp
69.9
fair_value_discount_or_premium_to_market
-0.344250957
expected_terminal_old_holder_mcap_oku
128.83522934
expected_preterminal_old_holder_payout_oku
12.60867303
interpretation

expected fair value from dated payout plus residual old cohort terminal equity, not market P/E or P/B normalization

事業

model

技術力・在庫・仕様適合・短納期等の付加価値を伴う特殊部品流通と小規模製造/サービス。分散型子会社を継続的に買収。

motors
内容を開く
1

Aerospace/defence interconnect demand

2

Data centres, energy electrification and critical wiring

3

Medical diagnostics, medtech consumables

4

Hercules Seals aftermarket and industrial OEM

5

Decentralized acquisition integration with pricing/tariff pass through

volume_vs_price
内容を開く
FY2025_organic_growth
0.11
FY2025_characterization

primary report says volume-led across all three sectors

FY2026_H1_organic_growth
0.15
FY2026_H1_Controls_organic_growth
0.26
FY2026_H1_Seals_organic_growth
0.02
FY2026_H1_Life_Sciences_organic_growth
0.04
independent_volume_split
未確認
independent_price_split
未確認
注記

volume and realized price effects not separately numerically provided in reviewed statements; impossible to verify each driver

M_and_A
内容を開く
since_2019_deals_at_H1_2026
57
invested_since_2019_gbp_m
1600
recent_LTM_deals_mentioned_at_2026_H1_including_pending
15
recent_LTM_spend_indicated_m
310
average_multiple_approx_EBITDA
8
CDM_completed

2026-06-25

CDM_defence_US_interconnect

c.80m USD revenue disclosed at H1

H1_2026_acquisitions_net_cash_gbp_m
82.4
H1_2026_acquired_goodwill_gbp_m
34
H1_2026_acquired_intangibles_gbp_m
46.4
unannounced_acquisitions_after_cutoff
未確認
revenue_recognition

Primarily sales of tangible products under IFRS 15, no speculative SaaS recurring-revenue multiple.

競争力・事業の質

scoring_scale

qualitative 1-5

organic_demand_quality
4
pricing_power
4
balance_sheet_quality
3
accounting_clarity
3
capital_allocation
4
principal_risks
内容を開く
1

M&A overpayment (goodwill+customer relationships)

2

loss of aerospace/defence/AI capex tailwinds

3

FX translation across GBP/ USD/ EUR

4

Cyclicality in industrial seals and diagnostic procurements

5

Debt fixed private placements mature 2031-2036; 2030 RCF renewal

6

Trust cash compensation despite noncash IFRS2 P&L expense

7

FY26 full year not yet published by 2026-11-06

nonIFRS_KPIs
内容を開く
2026_H1_ROATCE
0.227
2026_H1_fcf_conversion
0.76
2025_FY_ROATCE
0.209
2025_FY_fcf_conversion
1.05
normalized_tax_warning

statutory H1 2026 effective 27.83%, adjusted 25.0%; forecast statutory rates 25.5%-28.5% case assumptions

業界と環境

sector_mix_at_h1_2026
controls
0.581953
seals
0.264246
life_sciences
0.153801
defensibility

Application engineering, small bill-of-material share but critical uptime, technical sales, SKU and localized distribution

headwinds
内容を開く
1

Inventory normalization

2

Construction/agriculture and UK industrial softness

3

Healthcare budget constraint

4

Aerospace/defence customer concentration possibly unquantified

5

Manufacturing reshoring/tariffs

6

Sustainable ROIC after goodwill

endmarket_concentration_disclosed
未確認
geographical_revenue_FY2025_proforma
内容を開く
North_America
0.53
Europe
0.19
UK
0.18
Australia_other
0.1

財務・資本配分

reported_FY2025_as_of_2025_09_30
内容を開く
sales_oku
15.245
adj_op_oku
3.427
ifrs_op_oku
2.837
financial_net_expense_oku
0.354
pbt_oku
2.483
tax_oku
0.628
ni_parent_oku
1.849
sbc_exp_oku
0.062
親会社持分(億)
9.897
非支配持分資本(億)
0.045
現金(億)
0.817
debt_oku
3.811
leases_oku
0.838
goodwill_oku
5.635
acq_intang_oku
4.791
ebt_shares_at_2025_09_30
81368
issued_at_2025_09_30
134176207
ebt_funded_cash_oku
0.041
total_dividend_for_fy2025_pence
62.3
reported_FY2026_H1_as_of_2026_03_31
内容を開く
sales_oku
8.511
adj_op_oku
2.089
ifrs_op_oku
1.651
financial_net_expense_oku
0.257
pbt_oku
1.394
tax_oku
0.388
ni_parent_oku
1.003
ni_nci_oku
0.003
sbc_exp_oku
0.051
親会社持分(億)
10.522
非支配持分資本(億)
0.045
現金(億)
0.687
debt_oku
4.126
leases_oku
0.888
goodwill_oku
6.054
acq_intang_oku
4.992
acq_related_liabilities_oku
0.385
amort_acq_oku
0.324
basic_weighted_shares
134242804
diluted_weighted_shares
134777848
working_capital_outflow_oku
0.589
capex_oku
0.076
operating_cashflow_after_tax_oku
1.11
dividend_final_paid_oku
0.592
dividend_interim_declared_after_reporting_oku
0.257
reconstruction
内容を開く
basis_status

FY25 actual audited and H1 FY26 reviewed; FY26 September and November forecast bridge not a published financial statement

fy2026_fx_drag_to_revenue_assumed
-0.02
fy2026_organic_revenue_guidance_actual
0.14
fy2026_announced_acquisition_revenue_guidance_actual
0.06
fy2026_adjusted_operating_margin_guidance
0.265
fy2026_est_sales_oku
17.9891
fy2026_est_adj_operating_profit_oku
4.7671115
fy2026_est_IFRS_operating_profit_oku
3.8291115
fy2026_est_IFRS_parent_net_income_oku
2.3776115
h2_est_oct2025_to_mar2026_status

first half FY26 published

h2_est_apr2026_to_sep2026
内容を開く
sales_oku
9.4781
adj_op_oku
2.6781115
IFRS_op_oku
2.1781115
financial_net_expense_oku
0.32
PBT_oku
1.8581115
tax_oku
0.48
parent_net_income_oku
1.3746115
SBC_oku
0.055
parent_Other_OCI_oku
0
IFRS_parent_equity_change_oku
1.1531115
WC_cash_released_oku
0.2
acquisition_cash_oku
1.7
debt_draw_oku
0.4
interim_dividend_cash_oku
0.2565
EBT_funding_oku
0.02
estimated_2026_09_30
内容を開く
as_of

2026-09-30

sales_fy26_oku
17.9891
fy26_adjusted_op_oku
4.7671115
fy26_ifrs_operating_profit_oku
3.8291115
fy26_parent_net_income_oku
2.3776115
親会社持分(億)
11.6751115
現金(億)
1.1801115
debt_oku
4.526
非支配持分(億)
0.045
lease_liabilities_oku
0.928
goodwill_oku
6.754
acquired_intangibles_oku
5.432
deferred_acquisition_payable_oku
0.5
issuer_shares
134317398
自己株式数
0
ebt_shares_proxy
75000
rcf_debt_oku
1.204
pp_debt_oku
3.322
post_fy_to_cutoff_2026_10_01_through_11_06
内容を開く
days
37
annualization_denominator_days
365
sales_oku
1.96943681
adj_operating_profit_oku
0.51205357
IFRS_operating_profit_oku
0.43197664
net_finance_expense_oku
0.042
PBT_oku
0.38997664
tax_oku
0.10529369
parent_net_income_oku
0.28418295
SBC_non_cash_and_equity_oku
0.01181662
wc_cash_outflow_oku
0.11
cash_delta_oku
0.25134728
no_2026_FY_final_dividend_liability_or_CF_recognized_yet
はい
estimated_2026_11_06
内容を開く
親会社持分(億)
11.97111107
非支配持分資本(億)
0.0455
現金(億)
1.43145878
private_placement_debt_oku
3.322
revolving_credit_debt_oku
1.204
total_interest_bearing_debt_exleases_oku
4.526
lease_liabilities_oku
0.929
net_debt_oku
3.09454122
goodwill_oku
6.754
acquired_intangibles_oku
5.36592307
acquisition_deferred_obligations_oku
0.5
発行済株式数
134317398
自己株式数
0
EBT_proxy
75000
old_holder_shares
134242398
cash_debt_conventions

gross debt excludes IFRS16 lease liabilities; lease liabilities shown and principal cash out separately; the reported H1 net debt 343.9m = 412.6m borrowings -68.7m cash.

private_placement_maturity_schedule_fx_proxy
内容を開く
1
日付

2031-03-31

gbp_m_proxy
65.5
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

2
日付

2032-08-31

gbp_m_proxy
75.9
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

3
日付

2034-03-31

gbp_m_proxy
87.4
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

4
日付

2035-08-31

gbp_m_proxy
38
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

5
日付

2036-03-31

gbp_m_proxy
65.4
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

2026_03_31_undrawn_RCF_m
571
2026_03_31_RCF_total_m
655
RCF_2030_renewal

forecast necessary for horizon; not a contractual certainty

goodwill_and_acquired_intangibles_H1_m
goodwill_m
605.4
acquired_intangibles_m
499.2
total_m
1104.6
sbc_policy

IFRS reported NI includes SBC cost; company FY25 annual states equity-settled expense credited to equity; EBT open-market purchases charged to cash/equity once, and pro-rata old sellers get cash; newly issued shares to EBT at par are intra-group consolidated transfer with zero external proceeds.

EBT_historical
内容を開く
2025_09_30_verified
81368
2025_11_13_verified
222559
2026_11_06_unverified
未確認
opening_assumed_inventory
75000
2025_EBT_cash_funding_gbp_m
4.1
2026_H1_sbc_gbp_m
5.1
pre_cutoff_dividends
内容を開く
FY25_final_per_share_gbp
0.441
FY25_final_paid_date

2026-01-30

FY26_interim_per_share_gbp
0.191
FY26_interim_ex_date

2026-05-28

FY26_interim_record_date

2026-05-29

FY26_interim_pay_date

2026-06-12

注記

both before cutoff; not in holder CF after Nov 6

FY26_final_dividend_as_of_cutoff
内容を開く
amount_per_share
未確認
declared
いいえ
announced_date_expected

2026-11-17

planned_2027_ex_date

2027-01-14

planned_2027_payment

2027-01-29

pay_after_AGM_approval
はい
recognized_liability_at_2026_11_06
0
cashflow_included_before_2026_11_06
いいえ

評価の前提と確認

uses_market_P_E_for_terminal
いいえ
uses_market_P_B_for_terminal
いいえ
price_input_is_initial_CF_only
はい
market_repurchase_price_assumptions_used_only_for_future_share_transactions
はい
terminal_formula

(maintainable parent NI 2037 + SBC noncash - MAX(operational/acquisition/replacement reinvestment net of noncash addbacks, normalized g/ROE reinvestment floor))/(case cost of equity - perpetual growth + unfunded future share issuance dilution) + nonoperating excess cash; old cohort = total company equity value x old shares / eligible shares; dividend-available plus EBT seller proceeds reconciled to total FCFE.

NCI_double_subtract
いいえ
interest_bearing_debt_double_subtract
いいえ
book_equity_plus_terminal_market_cap_double_count
いいえ
sbc_non_cash_addback_once
はい
EBT_cash_purchase_expenditure_once
はい
funded_ebt_purchase_is_old_holder_cash_at_fair_market_price_and_reduces_old_share_count
はい
unfunded_new_shares_dilute_after_vesting
はい
terminal_dilution_rate_derived_from_2037_issuance_and_exit_shares
はい
one_pre_ex_sale_price_no_extra_post_exit_final_dividend
はい

資本コストの前提

資本コスト
9.20%
currency

GBP

nominal
はい
方法

build_up_nominal_cost_of_equity_central_assumption_not_market_PE

case_terminal_k_rates
内容を開く
severe_downside
0.117
downside
0.105
base
0.092
upside
0.087
exceptional
0.084
scenario_discount_for_pv
0.092

事業別データ

事業別の内訳と、収録されている年度別データを確認できます。

事業別データを開く →

10年のシナリオ

シナリオごとの確率、期間内の株主還元・追加負担、終価です。金額は億GBP。株主の範囲や受取時点は各分析の前提を確認してください。

シナリオ確率株主還元・追加負担終価
極めて強気10.0%17.82287.76
強気20.0%14.54188.42
中立40.0%12.29118.08
弱気20.0%10.7559.08
深刻な下振れ10.0%8.5333.27

極めて強気(確率 10.0%)

高い有機成長の長期持続とROATCE高水準、再投資の成功

確率の根拠

シナリオ確率は分析上の仮定です。

このシナリオの数値・キャッシュフローを開く →

強気(確率 20.0%)

宇宙・航空・防衛とエネルギー/データセンターが拡大、M&A相乗効果

確率の根拠

シナリオ確率は分析上の仮定です。

このシナリオの数値・キャッシュフローを開く →

中立(確率 40.0%)

Controls高付加価値、Seals回復、M&A買付価格規律、配当+5%

確率の根拠

シナリオ確率は分析上の仮定です。

このシナリオの数値・キャッシュフローを開く →

弱気(確率 20.0%)

Controls成長鈍化、物流在庫負担、金利・のれん償却が残る

確率の根拠

シナリオ確率は分析上の仮定です。

このシナリオの数値・キャッシュフローを開く →

深刻な下振れ(確率 10.0%)

軍需/データセンターの需要反転、のれん減損・高金利・連続買収の低収益

確率の根拠

シナリオ確率は分析上の仮定です。

このシナリオの数値・キャッシュフローを開く →

単位の説明

financial_oku

億GBP (1 oku GBP = 100,000,000 GBP = 100 GBP million)

all_pct_rates

decimal

価格・単価

GBP per ordinary share, GBp raw quote separately

share_count

ordinary shares / pro-rata equivalent old cohort

year

calendar-day difference divided by 365.25

事業の詳細

model

技術力・在庫・仕様適合・短納期等の付加価値を伴う特殊部品流通と小規模製造/サービス。分散型子会社を継続的に買収。

motors
内容を開く
1

Aerospace/defence interconnect demand

2

Data centres, energy electrification and critical wiring

3

Medical diagnostics, medtech consumables

4

Hercules Seals aftermarket and industrial OEM

5

Decentralized acquisition integration with pricing/tariff pass through

volume_vs_price
内容を開く
FY2025_organic_growth
0.11
FY2025_characterization

primary report says volume-led across all three sectors

FY2026_H1_organic_growth
0.15
FY2026_H1_Controls_organic_growth
0.26
FY2026_H1_Seals_organic_growth
0.02
FY2026_H1_Life_Sciences_organic_growth
0.04
independent_volume_split
未確認
independent_price_split
未確認
注記

volume and realized price effects not separately numerically provided in reviewed statements; impossible to verify each driver

M_and_A
内容を開く
since_2019_deals_at_H1_2026
57
invested_since_2019_gbp_m
1600
recent_LTM_deals_mentioned_at_2026_H1_including_pending
15
recent_LTM_spend_indicated_m
310
average_multiple_approx_EBITDA
8
CDM_completed

2026-06-25

CDM_defence_US_interconnect

c.80m USD revenue disclosed at H1

H1_2026_acquisitions_net_cash_gbp_m
82.4
H1_2026_acquired_goodwill_gbp_m
34
H1_2026_acquired_intangibles_gbp_m
46.4
unannounced_acquisitions_after_cutoff
未確認
revenue_recognition

Primarily sales of tangible products under IFRS 15, no speculative SaaS recurring-revenue multiple.

競争力の詳細

scoring_scale

qualitative 1-5

organic_demand_quality
4
pricing_power
4
balance_sheet_quality
3
accounting_clarity
3
capital_allocation
4
principal_risks
内容を開く
1

M&A overpayment (goodwill+customer relationships)

2

loss of aerospace/defence/AI capex tailwinds

3

FX translation across GBP/ USD/ EUR

4

Cyclicality in industrial seals and diagnostic procurements

5

Debt fixed private placements mature 2031-2036; 2030 RCF renewal

6

Trust cash compensation despite noncash IFRS2 P&L expense

7

FY26 full year not yet published by 2026-11-06

nonIFRS_KPIs
内容を開く
2026_H1_ROATCE
0.227
2026_H1_fcf_conversion
0.76
2025_FY_ROATCE
0.209
2025_FY_fcf_conversion
1.05
normalized_tax_warning

statutory H1 2026 effective 27.83%, adjusted 25.0%; forecast statutory rates 25.5%-28.5% case assumptions

業界の詳細

sector_mix_at_h1_2026
controls
0.581953
seals
0.264246
life_sciences
0.153801
defensibility

Application engineering, small bill-of-material share but critical uptime, technical sales, SKU and localized distribution

headwinds
内容を開く
1

Inventory normalization

2

Construction/agriculture and UK industrial softness

3

Healthcare budget constraint

4

Aerospace/defence customer concentration possibly unquantified

5

Manufacturing reshoring/tariffs

6

Sustainable ROIC after goodwill

endmarket_concentration_disclosed
未確認
geographical_revenue_FY2025_proforma
内容を開く
North_America
0.53
Europe
0.19
UK
0.18
Australia_other
0.1

財務・資本配分の詳細

reported_FY2025_as_of_2025_09_30
内容を開く
sales_oku
15.245
adj_op_oku
3.427
ifrs_op_oku
2.837
financial_net_expense_oku
0.354
pbt_oku
2.483
tax_oku
0.628
ni_parent_oku
1.849
sbc_exp_oku
0.062
親会社持分(億)
9.897
非支配持分資本(億)
0.045
現金(億)
0.817
debt_oku
3.811
leases_oku
0.838
goodwill_oku
5.635
acq_intang_oku
4.791
ebt_shares_at_2025_09_30
81368
issued_at_2025_09_30
134176207
ebt_funded_cash_oku
0.041
total_dividend_for_fy2025_pence
62.3
reported_FY2026_H1_as_of_2026_03_31
内容を開く
sales_oku
8.511
adj_op_oku
2.089
ifrs_op_oku
1.651
financial_net_expense_oku
0.257
pbt_oku
1.394
tax_oku
0.388
ni_parent_oku
1.003
ni_nci_oku
0.003
sbc_exp_oku
0.051
親会社持分(億)
10.522
非支配持分資本(億)
0.045
現金(億)
0.687
debt_oku
4.126
leases_oku
0.888
goodwill_oku
6.054
acq_intang_oku
4.992
acq_related_liabilities_oku
0.385
amort_acq_oku
0.324
basic_weighted_shares
134242804
diluted_weighted_shares
134777848
working_capital_outflow_oku
0.589
capex_oku
0.076
operating_cashflow_after_tax_oku
1.11
dividend_final_paid_oku
0.592
dividend_interim_declared_after_reporting_oku
0.257
reconstruction
内容を開く
basis_status

FY25 actual audited and H1 FY26 reviewed; FY26 September and November forecast bridge not a published financial statement

fy2026_fx_drag_to_revenue_assumed
-0.02
fy2026_organic_revenue_guidance_actual
0.14
fy2026_announced_acquisition_revenue_guidance_actual
0.06
fy2026_adjusted_operating_margin_guidance
0.265
fy2026_est_sales_oku
17.9891
fy2026_est_adj_operating_profit_oku
4.7671115
fy2026_est_IFRS_operating_profit_oku
3.8291115
fy2026_est_IFRS_parent_net_income_oku
2.3776115
h2_est_oct2025_to_mar2026_status

first half FY26 published

h2_est_apr2026_to_sep2026
内容を開く
sales_oku
9.4781
adj_op_oku
2.6781115
IFRS_op_oku
2.1781115
financial_net_expense_oku
0.32
PBT_oku
1.8581115
tax_oku
0.48
parent_net_income_oku
1.3746115
SBC_oku
0.055
parent_Other_OCI_oku
0
IFRS_parent_equity_change_oku
1.1531115
WC_cash_released_oku
0.2
acquisition_cash_oku
1.7
debt_draw_oku
0.4
interim_dividend_cash_oku
0.2565
EBT_funding_oku
0.02
estimated_2026_09_30
内容を開く
as_of

2026-09-30

sales_fy26_oku
17.9891
fy26_adjusted_op_oku
4.7671115
fy26_ifrs_operating_profit_oku
3.8291115
fy26_parent_net_income_oku
2.3776115
親会社持分(億)
11.6751115
現金(億)
1.1801115
debt_oku
4.526
非支配持分(億)
0.045
lease_liabilities_oku
0.928
goodwill_oku
6.754
acquired_intangibles_oku
5.432
deferred_acquisition_payable_oku
0.5
issuer_shares
134317398
自己株式数
0
ebt_shares_proxy
75000
rcf_debt_oku
1.204
pp_debt_oku
3.322
post_fy_to_cutoff_2026_10_01_through_11_06
内容を開く
days
37
annualization_denominator_days
365
sales_oku
1.96943681
adj_operating_profit_oku
0.51205357
IFRS_operating_profit_oku
0.43197664
net_finance_expense_oku
0.042
PBT_oku
0.38997664
tax_oku
0.10529369
parent_net_income_oku
0.28418295
SBC_non_cash_and_equity_oku
0.01181662
wc_cash_outflow_oku
0.11
cash_delta_oku
0.25134728
no_2026_FY_final_dividend_liability_or_CF_recognized_yet
はい
estimated_2026_11_06
内容を開く
親会社持分(億)
11.97111107
非支配持分資本(億)
0.0455
現金(億)
1.43145878
private_placement_debt_oku
3.322
revolving_credit_debt_oku
1.204
total_interest_bearing_debt_exleases_oku
4.526
lease_liabilities_oku
0.929
net_debt_oku
3.09454122
goodwill_oku
6.754
acquired_intangibles_oku
5.36592307
acquisition_deferred_obligations_oku
0.5
発行済株式数
134317398
自己株式数
0
EBT_proxy
75000
old_holder_shares
134242398
cash_debt_conventions

gross debt excludes IFRS16 lease liabilities; lease liabilities shown and principal cash out separately; the reported H1 net debt 343.9m = 412.6m borrowings -68.7m cash.

private_placement_maturity_schedule_fx_proxy
内容を開く
1
日付

2031-03-31

gbp_m_proxy
65.5
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

2
日付

2032-08-31

gbp_m_proxy
75.9
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

3
日付

2034-03-31

gbp_m_proxy
87.4
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

4
日付

2035-08-31

gbp_m_proxy
38
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

5
日付

2036-03-31

gbp_m_proxy
65.4
face_value_currency_and_origination

EUR and USD notes; amount FX-proxied from March 2026 GBP carrying

2026_03_31_undrawn_RCF_m
571
2026_03_31_RCF_total_m
655
RCF_2030_renewal

forecast necessary for horizon; not a contractual certainty

goodwill_and_acquired_intangibles_H1_m
goodwill_m
605.4
acquired_intangibles_m
499.2
total_m
1104.6
sbc_policy

IFRS reported NI includes SBC cost; company FY25 annual states equity-settled expense credited to equity; EBT open-market purchases charged to cash/equity once, and pro-rata old sellers get cash; newly issued shares to EBT at par are intra-group consolidated transfer with zero external proceeds.

EBT_historical
内容を開く
2025_09_30_verified
81368
2025_11_13_verified
222559
2026_11_06_unverified
未確認
opening_assumed_inventory
75000
2025_EBT_cash_funding_gbp_m
4.1
2026_H1_sbc_gbp_m
5.1
pre_cutoff_dividends
内容を開く
FY25_final_per_share_gbp
0.441
FY25_final_paid_date

2026-01-30

FY26_interim_per_share_gbp
0.191
FY26_interim_ex_date

2026-05-28

FY26_interim_record_date

2026-05-29

FY26_interim_pay_date

2026-06-12

注記

both before cutoff; not in holder CF after Nov 6

FY26_final_dividend_as_of_cutoff
内容を開く
amount_per_share
未確認
declared
いいえ
announced_date_expected

2026-11-17

planned_2027_ex_date

2027-01-14

planned_2027_payment

2027-01-29

pay_after_AGM_approval
はい
recognized_liability_at_2026_11_06
0
cashflow_included_before_2026_11_06
いいえ

評価根拠の詳細

uses_market_P_E_for_terminal
いいえ
uses_market_P_B_for_terminal
いいえ
price_input_is_initial_CF_only
はい
market_repurchase_price_assumptions_used_only_for_future_share_transactions
はい
terminal_formula

(maintainable parent NI 2037 + SBC noncash - MAX(operational/acquisition/replacement reinvestment net of noncash addbacks, normalized g/ROE reinvestment floor))/(case cost of equity - perpetual growth + unfunded future share issuance dilution) + nonoperating excess cash; old cohort = total company equity value x old shares / eligible shares; dividend-available plus EBT seller proceeds reconciled to total FCFE.

NCI_double_subtract
いいえ
interest_bearing_debt_double_subtract
いいえ
book_equity_plus_terminal_market_cap_double_count
いいえ
sbc_non_cash_addback_once
はい
EBT_cash_purchase_expenditure_once
はい
funded_ebt_purchase_is_old_holder_cash_at_fair_market_price_and_reduces_old_share_count
はい
unfunded_new_shares_dilute_after_vesting
はい
terminal_dilution_rate_derived_from_2037_issuance_and_exit_shares
はい
one_pre_ex_sale_price_no_extra_post_exit_final_dividend
はい

不確実性

1
item

2026-11-06 close primary intraday/eod bar

状態

unconfirmed_official_timestamp

fallback

secondary dated FT and StockAnalysis show 6990 GBp; official LSE day row not retrieved

2
item

2026-09-30 FY26 audited accounts not announced until 2026-11-17

状態

estimated_bridge_not_actual

implication

FY26 revenue, cash, debt, parent equity, goodwill are pre-release proxies

3
item

2026-11-06 EBT shares

状態

unverified

fallback

75000 initial; test 0/81368/222559; FY2026 H1 weighted average eligible 134242804 is NOT a point-in-time closing sharecount

4
item

post-Nov-2026 dividends and issuer buybacks

状態

forecast_only

implication

2027 Jan ex and payment dates appear on official calendar but dividend amount still unannounced at cutoff; all cashflow amounts scenario assumptions

5
item

2030 revolving credit facility renewal and 2028 bilateral extension

状態

uncontracted_future_refinancing

implication

interest expense and liquidity assumptions can fail under a stress scenario

6
item

EBT actual vest/market buying vs nominal new issue

状態

assumed

implication

70% secondary purchases, 30% new EBT shares at 5p are modeled proxy; award outcomes depend on schemes, taxes, exercisability

7
item

future M&A targets, goodwill recognition, tax and finance marks

状態

scenario_assumption

implication

the 10-year path is not reported management guidance

8
item

terminal perpetuity ROE and continuing normalized reinvestment

状態

model_assumption

implication

sensitivity to g and k is high, especially for high-multiple stock

分析基準とデータ

as_of

2026-11-06

価格・単価
69.9
price_gbp
69.9
quote_raw_gbp_pence
6990
price_source_tier

secondary_verified_proxy_primary_day_bar_unavailable

price_cross_validation_sources
1

s09

2

s10

3

s11

株数
134242398
shares_unit

ordinary_shares

shares_kind

old_eligible_external_ordinary_share_cohort_excluding_EBT_proxy

発行済株式数
134317398
自己株式数
0
ebt_shares_proxy
75000
trust_shares_verified_2025_09_30
81368
trust_shares_verified_2025_11_13
222559
trust_shares_exact_at_2026_11_06
未確認
market_cap_on_eligible_cohort_oku
93.8354362
issued_total_quote_value_including_EBT_oku
93.8878612
initial_cfo_baseline_cutoff_balance_is_proxy
はい
sharecount_primary_basis

2025-11-13 RNS /2025-11-30 TVR; 2026-10-23 TR1 percentage supports unchanged total; EBT 2026 close undisclosed

share_count_sensitivity_ebt_inventory
内容を開く
1
内容を開く
initial_eligible_shares
134317398
fair_value_per_share_gbp_at_k_9_2pct
45.81275469
prob_weighted_cashflow_irr
0.043934374105
注記

other financial drivers identical; EBT opening inventory proxy only

81369
内容を開く
initial_eligible_shares
134236030
fair_value_per_share_gbp_at_k_9_2pct
45.83890583
prob_weighted_cashflow_irr
0.043998901839
注記

other financial drivers identical; EBT opening inventory proxy only

75001
内容を開く
initial_eligible_shares
134242398
fair_value_per_share_gbp_at_k_9_2pct
45.83685808
prob_weighted_cashflow_irr
0.04399385033
注記

other financial drivers identical; EBT opening inventory proxy only

222560
内容を開く
initial_eligible_shares
134094839
fair_value_per_share_gbp_at_k_9_2pct
45.88435757
prob_weighted_cashflow_irr
0.044110967459
注記

other financial drivers identical; EBT opening inventory proxy only

株価の出所

London Stock Exchange DPLM 2026-11-06 close 6,990 pence

株数の出所

2025-11-30 voting rights 134,317,398, minus 75,000 employee trust proxy; 2026-11-06 exact EBT shares unverified

追加データ・検証記録

記載なし

分析に使用した資料

← AI銘柄分析一覧へ戻る ヒートマップを見る →